Rampart Investment Management Company LLC decreased its position in Agilent Technologies Inc (NYSE:A) by 9.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,480 shares of the medical research company’s stock after selling 1,089 shares during the period. Rampart Investment Management Company LLC’s holdings in Agilent Technologies were worth $783,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently modified their holdings of the company. Dimensional Fund Advisors LP increased its position in shares of Agilent Technologies by 4.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,031,349 shares of the medical research company’s stock worth $69,567,000 after purchasing an additional 47,062 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Agilent Technologies by 7.2% during the 4th quarter. Geode Capital Management LLC now owns 4,234,035 shares of the medical research company’s stock worth $285,139,000 after purchasing an additional 285,330 shares during the last quarter. Moors & Cabot Inc. acquired a new position in shares of Agilent Technologies during the 1st quarter worth approximately $306,000. Raymond James Financial Services Advisors Inc. raised its position in shares of Agilent Technologies by 7.6% during the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 29,497 shares of the medical research company’s stock worth $2,371,000 after purchasing an additional 2,090 shares during the last quarter. Finally, Raymond James & Associates raised its position in shares of Agilent Technologies by 38.3% during the 1st quarter. Raymond James & Associates now owns 113,917 shares of the medical research company’s stock worth $9,157,000 after purchasing an additional 31,559 shares during the last quarter.
A has been the subject of several analyst reports. Barclays downgraded Agilent Technologies from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $86.00 to $78.00 in a report on Monday, July 15th. Piper Jaffray Companies upped their price target on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, August 15th. Wolfe Research started coverage on shares of Agilent Technologies in a research report on Thursday, May 30th. They set a “peer perform” rating for the company. Needham & Company LLC upped their price objective on shares of Agilent Technologies to $92.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Finally, Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price objective for the company. in a research report on Tuesday, July 16th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $85.00.
Shares of NYSE:A traded up $0.53 during trading hours on Thursday, hitting $78.10. The stock had a trading volume of 84,106 shares, compared to its average volume of 2,328,294. The stock’s fifty day simple moving average is $71.22 and its 200 day simple moving average is $73.92. Agilent Technologies Inc has a 1-year low of $61.01 and a 1-year high of $82.27. The firm has a market capitalization of $23.88 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 2.13 and a beta of 1.40. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.72 and a current ratio of 2.13.
Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.72 by $0.04. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.24 billion. Agilent Technologies had a net margin of 21.06% and a return on equity of 20.00%. Agilent Technologies’s revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.67 earnings per share. As a group, research analysts anticipate that Agilent Technologies Inc will post 3.08 EPS for the current year.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: What is the formula for calculating total return?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.